Compare Sari Kreasi Boga Tbk. (RAFI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sari Kreasi Boga Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Sari Kreasi Boga Tbk. trades at Rp36 (market cap 115.74B, 1.83M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Sari Kreasi Boga Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| RAFI | SCPI | |
|---|---|---|
Market Cap | 115.74B | 104.4B |
Volume | 1.83M | — |
Lot | 18.26K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sari Kreasi Boga Tbk.
PT Sari Kreasi Boga Tbk (the Company) was established based on Deed No. 29 dated July 17, 2017 made before Notary Mahendra Adinegara, S.H., M.Kn. in Jakarta.
Read more on RAFI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
